| Literature DB >> 35518865 |
Hend Aly1, Ahmed S El-Shafie1, Marwa El-Azazy1.
Abstract
A simple and highly sensitive univariate calibration strategy based on ultraviolet-visible (UV-Vis) absorption spectroscopy and assisted by multivariate screening and optimization was utilized for the determination of l-ornithine (l-ORN) as such and in the alimentary supplements. l-ORN, an OTC marketed amino acid, is widely used for bodybuilding and might be abused by athletes. A nucleophilic substitution reaction using 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) was the basis of the current investigation. Plackett-Burman design (PBD) and a response surface optimizer as screening and fine-tuning strategies, respectively, were instigated. Four numerical variables, reaction time (RT), temperature (Temp), pH and reagent volume (RV), and one categorical variable, the diluting solvent (DS), were considered. Absorbance of the yellow-colored adduct at 469 nm was the response studied. Pareto analysis, along with analysis of variance (ANOVA) were used to ascertain the significant variables (screening phase) and their domains (optimization phase). Response transformation and stepwise analysis were employed when necessary. Probability, cube and individual value plots were used to get an insight into the statistical impact of the variables tested. Multiple responses' optimization was performed using Derringer's function. Calibration curves were linear in the range of 5-50 μg mL-1. Job's technique of continuous variation showed that the stoichiometric ratio is 2 : 1 (NBD-Cl : l-ORN). The proposed technique was successfully applied to the dietary supplements of l-ORN, inferring no interference from adjuvants and excipients. Analytical performance of this technique was validated conforming to the ICH standards. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35518865 PMCID: PMC9066740 DOI: 10.1039/c9ra03311d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Scheme 1l-Ornithine monohydrochloride (l-ORN).
Scheme 27-Chloro-4-nitrobenzo-2-oxa-1,3-diazole.
Experimental setup and the obtained responses using PBDa
| Run no | Variables | Response | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| E |
|
|
| |
| 01 | 9 | 67.5 | 20 | 1.1 | Water | 0.0021 | 0.0521 | 0.0037 |
| 02 | 11 | 80 | 5 | 2.0 | Methanol | 0.1040 | 0.1451 | 0.1691 |
| 03 | 7 | 55 | 35 | 2.0 | Methanol | 0.2440 | 0.3476 | 0.2880 |
| 04 | 7 | 55 | 5 | 2.0 | Methanol | 0.0554 | 0.1378 | 0.0814 |
| 05 | 7 | 80 | 35 | 0.2 | Methanol | 0.1966 | 0.1916 | 0.1036 |
| 06 | 7 | 80 | 35 | 2.0 | Water | 0.7346 | 0.5332 | 0.9830 |
| 07 | 7 | 80 | 5 | 0.2 | Water | 0.0391 | 0.0776 | 0.0264 |
| 08 | 7 | 55 | 5 | 0.2 | Water | 0.0058 | 0.0086 | 0.0070 |
| 09 | 9 | 67.5 | 20 | 1.1 | Methanol | 0.0040 | 0.0043 | 0.0041 |
| 10 | 11 | 80 | 5 | 2.0 | Water | 0.1871 | 0.2408 | 0.1526 |
| 11 | 11 | 55 | 35 | 0.2 | Water | 0.0058 | 0.1148 | 0.0136 |
| 12 | 9 | 67.5 | 20 | 1.1 | Water | 0.0045 | 0.0521 | 0.0037 |
| 13 | 11 | 55 | 35 | 2.0 | Water | 0.0890 | 0.3607 | 0.1428 |
| 14 | 11 | 55 | 5 | 0.2 | Methanol | 0.0068 | 0.0191 | 0.0043 |
| 15 | 9 | 67.5 | 20 | 1.1 | Methanol | 0.0063 | 0.0436 | 0.0041 |
| 16 | 11 | 80 | 35 | 0.2 | Methanol | 0.0360 | 0.1090 | 0.0569 |
(pH, (A)), (temperature, Temp (B), °C), (reaction time, RT, (C) min), (reagent volume, RV, (D) mL), (solvent type, DS, (E) methanol or distilled water), absorbance (Abs at 469 nm). *Experimental values for Y1. **Predicted values before response transformation: Y1** = −0.176 − 0.0207pH + 0.00360Temp + 0.00699RT + 0.1366volume of NBD-Cl − 0.0479DS − 0.1670Ct Pt. ***Predicted values after response transformation: ln(Y1***) = −7.26 − 0.1499pH + 0.0532Temp + 0.0421RT + 1.307volume of NBD-Cl + 0.051 DS − 2.801Ct Pt.
Scheme 3Reaction of NBD-Cl with primary amines.
Fig. 1Absorption spectrum for the reaction of l-ORN with NBD-Cl under optimal conditions. The optimal conditions are Temp = 80 °C, pH = 7, RT = 35 min, and RV = 2 mL.
Fig. 2Absorption spectrum for sample 13 (Table 2) showing the formation of a second peak at 500 nm after the decomposition of the peak at 469 nm.
Fig. 3Pareto chart of standardized effects for Y1 following the response transformation.
Analysis of variance (ANOVA) for transformed responsea
| Source | DF | Adj SS | Adj MS |
|
|
|---|---|---|---|---|---|
| Model | 6 | 51.3504 | 8.5584 | 18.80 | 0.000 |
| Linear | 5 | 27.8093 | 5.5619 | 12.22 | 0.001 |
| pH | 1 | 1.0780 | 1.0780 | 2.37 | 0.158 |
| Temp | 1 | 5.3026 | 5.3026 | 11.65 | 0.008 |
| RT | 1 | 4.7855 | 4.7855 | 10.51 | 0.010 |
| RV | 1 | 16.6014 | 16.6014 | 36.46 | 0.000 |
| DS | 1 | 0.0417 | 0.0417 | 0.09 | 0.769 |
| Curvature | 1 | 23.5411 | 23.5411 | 51.70 | 0.000 |
| Error | 9 | 4.0979 | 0.4553 | ||
| Lack-of-fit | 7 | 3.7043 | 0.5292 | 2.69 | 0.298 |
| Pure error | 2 | 0.3936 | 0.1968 | ||
| Total | 15 | 55.4483 |
DF is degrees of freedom; SS is sum of squares; and MS is mean of squares.
Fig. 4Probability plot for the absorbance of the NBD-derivative measured at 469 nm following response transformation. Data points were grouped according to the employed diluting solvent, DS. The external lines on the graph are confidence intervals for the individual percentiles. Lognormal data distribution fitting was implemented.
Fig. 5Individual value plot with added interval bars at 95.0 CI.
Fig. 6Histogram plot.
Descriptive statistics for the 2-sample t-testa
| Response variable | Solvent type |
| Mean | SD | SE mean |
|---|---|---|---|---|---|
| Transformed response | Water | 8 | 0.177 | 0.272 | 0.096 |
| Methanol | 8 | 0.0816 | 0.0927 | 0.033 |
Null hypothesis: H0: μ1 − μ2 = 0. Alternative hypothesis: H1: μ1 − μ2 ≠ 0. T-value = 0.94, DF: 8; P-value = 0.374.
Fig. 7Cube plot for the fitted means of Y1 of the l-ORN–NBD-Cl reaction product.
Fig. 8Main effects plot using PBD and following response transformation.
Fig. 9Two-dimensional (2D) contour and three-dimensional (3D) surface plots.
Fig. 10Desirability plots.
Analytical parameters for the determination of l-ORN
| Parameter | Value | Parameter | Value |
|---|---|---|---|
| Wavelength, | 469 | Slope ( | 0.0180 |
| Linear range, (μg mL−1) | 5.00–50.00 | Intercept ( | 0.1036 |
|
| 2.41 × 10−4 |
| 0.9991 |
| ±t | 1.67 × 10−4 | LOD (μg mL−1) | 1.77 |
|
| 6.90 × 10−3 | LOQ (μg mL−1) | 5.38 |
| ±t | 4.78 × 10−3 | Residual SS | 4.70 × 10−4 |
|
| 9.69 × 10−3 | Regression SS | 0.5257 |
Regression equation: Y = bX + a, where Y is the absorbance, X is concentration in M, a is the intercept, b is the slope, S = SD of slope, ±tS = confidence limit for slope, S = SD of intercept ± tS = confidence limit for intercept S = SD of the regression, SS is sum of squares.
LOD = limit of detection, LOQ = limit of quantification, and r2 = coefficient of determination.
Results obtained by the proposed methods for the determination of l-ORN using NBD-Cl in authentic form and in pharmaceutical preparation compared to the reported method[11]
| Parameter | Proposed method | Reported method[ | Now Foods® capsules |
|---|---|---|---|
| Mean | 99.84 | 98.69 | 100.9 |
| ±SD | 1.491 | 1.56 | 1.10 |
| RSD | 1.494 | 1.58 | 1.09 |
|
| 2.22 | 2.13 | 1.21 |
|
| 7 | 3 | 6 |
| ±SE | 0.564 | 0.400 | 0.450 |
|
| 1.083 (2.262)a | ||
|
| 1.04 (19.3)b |
Average of 3 determinations; a and b are the tabulated t-values and F-ratios at p = 0.05.
| Variables | Low (−1) | Center point (0) | High (+1) |
|---|---|---|---|
| Numerical variables | |||
| pH, | 7 | 9 | 11 |
| Temperature (°C), | 55 | 67.5 | 80 |
| Reaction time (min), | 5 | 30 | 35 |
| Reagent volume (mL), | 0.2 | 1.1 | 2 |
| Categorical variables | ||
| Diluting solvent, E | Distilled water (DW) | Methanol (MeOH) |
| Taken (μg mL−1) | Found (μg mL−1) | % recovery |
|---|---|---|
|
| ||
| 5.00 | 4.97 | 99.33 |
| 10.00 | 9.97 | 99.67 |
| 15.00 | 14.66 | 97.76 |
| 20.00 | 20.18 | 100.9 |
| 30.00 | 30.08 | 100.3 |
| 40.00 | 40.91 | 100.3 |
| 50.00 | 49.32 | 98.63 |
| Mean | 99.84 ± 1.49 | |
| RSD | 1.494 | |
|
| ||
| 10.00 | 9.97 | 99.67 |
| 15.00 | 14.68 | 97.87 |
| 20.00 | 20.08 | 100.4 |
| 30.00 | 30.61 | 102.0 |
| 40.00 | 40.63 | 101.6 |
| 50.00 | 49.55 | 99.10 |
| Mean | 100.10 ± 1.55 | |
| RSD | 1.55 | |
Mean ± SD of 3 determinations. (a) The intra-day (n = 3) average of three concentrations of l-Ornithine repeated three times within the same day. (b) The inter-day (n = 3) average of three concentrations of l-ORN repeated three times in three different days.
| Taken (μg mL−1) | Added (μg mL−1) | % recovery |
|---|---|---|
|
| ||
| 15.00 | — | 99.96 |
| 15.00 | 5 | 99.60 |
| 15.00 | 10 | 100.1 |
| 15.00 | 15 | 101.1 |
| 15.00 | 20 | 101.4 |
| 15.00 | 30 | 102.61 |
| 15.00 | 35 | 101.76 |
| Mean | 100.93 ± 1.01 | |
| RSD | 1.09 | |
| Concentration (μg mL−1) | Mean% recovery | Error (%) |
|---|---|---|
|
| ||
| (a) Inter-day | ||
| 20.00 | 99.38 ± 1.21 | 0.62 |
| 30.00 | 98.00 ± 0.70 | 0.64 |
| 50.00 | 100.3 ± 1.1 | 0.87 |
| (b) Intra-day | ||
| 20.00 | 99.70 ± 0.75 | 0.30 |
| 30.00 | 99.53 ± 1.04 | 0.47 |
| 50.00 | 99.04 ± 1.06 | 0.96 |
|
| ||
| (a) Inter-day | ||
| 10.00 | 100.2 ± 0.6 | −0.23 |
| 40.00 | 98.28 ± 1.62 | 1.72 |
| 50.00 | 99.53 ± 1.50 | 0.47 |
| (b) Intra-day | ||
| 10.00 | 100.33 ± 0.76 | −0.33 |
| 40.00 | 98.97 ± 1.00 | 0.45 |
| 50.00 | 99.55 ± 1.09 | 1.03 |